PDB71 - ASSESSING THE RELATIVE COST-EFFECTIVENESS OF...

PDB71 - ASSESSING THE RELATIVE COST-EFFECTIVENESS OF EMPAGLIFLOZIN AND CANAGLIFLOZIN FOR THE TREATMENT OF TYPE 2 DIABETES PATIENTS WITH EXISTING CARDIOVASCULAR DISEASE IN THE UK

Webster, S., Hau, N., Ustyugova, A.V., Kansal, A.R., Reifsnider, O.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.776
Date:
October, 2018
File:
PDF, 378 KB
english, 2018
Conversion to is in progress
Conversion to is failed